| 692 |
a |
Upper abdominal/Oesophageal reflux symptoms that persist in patients that have been tested and received treatment for Helicobacter pylori |
| 693 |
b |
Upper abdominal symptoms or signs suggesting organic disease in patients > 45 years old |
| 694 |
c |
Dysphagia or Odynophagia |
| 695 |
d |
Upper abdominal/Oesophageal reflux symptoms that are persistent or recurrent in patients who have been treated with a trial of PPIs for 6 weeks or more |
| 696 |
e |
Persistent vomiting of unknown cause |
| 697 |
f |
Biopsy for suspected coeliac disease |
| 698 |
g |
Other diseases in which the presence of upper GI pathologic conditions might modify other planned management (i.e. patients who have a history of ulcer or GI bleeding who are scheduled for organ transplantation, long term anti-coagulation or long-term non-steroidal anti-inflammatory drug therapy for arthritis, and those with cancer of the head and neck) |
| 712 |
h |
For confirmation and specific histological diagnosis of radiologically demonstrated suspected or suspected upper GI tract lesion |
| 701 |
i |
Patients with active/recent GI bleeding |
| 713 |
j |
Iron deficiency anaemia |
| 702 |
k |
Patients with suspected portal hypertension to document or treat oesophageal varices |
| 703 |
l |
To assess acute injury after caustic ingestion |
| 704 |
m |
Treatment of bleeding lesions such as ulcers, tumours, vascular abnormalities (e.g. electro-coagulation, heater probe, laser photocoagulation, or injection therapy) |
| 709 |
n |
Further investigation of suspected achalasia |
| 808 |
o |
Pernicious Anaemia: Benefit will be provided for a single endoscopy |
| 782 |
p |
Other exceptional reasons will be considered provided a comprehensive medical report accompanies the claim outlining the medical necessity for the procedure |
| 620 |
pa |
Unexplained weight loss |
| 621 |
pb |
Further investigation of an upper abdominal mass |
| 622 |
pc |
Early satiety |